Shares of Novavax Inc. /zigman2/quotes/202614340/composite NVAX -2.88% advanced 6.12% to $94.80 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.45% rising 0.00% to 35,091.13 and the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP -0.52% falling 0.58% to 14,015.67. This was the stock's second consecutive day of gains. Novavax Inc. closed $236.88 short of its 52-week high ($331.68), which the company achieved on February 9th.
The stock outperformed some of its competitors Monday, as Replimune Group Inc. /zigman2/quotes/203971249/composite REPL +2.15% rose 2.79% to $18.77, VBI Vaccines Inc. /zigman2/quotes/201705917/composite VBIV -2.10% rose 4.52% to $1.62, and AnaptysBio Inc. /zigman2/quotes/205822596/composite ANAB +0.72% rose 1.15% to $31.73. Trading volume (6.4 M) remained 222,702 below its 50-day average volume of 6.7 M.